US$ 24.59
glp 1 drugs non injectable Comparing Ozempic, Wegovy and Other GLP-1 Most obesity drugs do not
Description
Back Baden, A (14 May 2025) 'People who stop weight loss drugs return to original weight within year, analysis finds', The Guardian

There isnt an official FDA-approved generic version of semaglutide

While previous generations GLP-1 agonists (liraglutide) have led to weight loss of 5-10% in most cases, semaglutide can lead to weight loss of up to 20%

Is there a community or support group

When weight and metabolic risk factors return, cardiovascular risk can also rise again

This means the drug could be a lot longer acting reducing dosing to potentially just once every two months
